Kom et al., Diabetes Care 2025: commentary describing GLP-1 and GLP-1/GIP multidose-pen fractional titration below the FDA-approved starting dose for GI tolerability, drug transitions, or cost
Patients should increase fluid intake, focusing on water, clear broths, and oral rehydration solutions containing electrolytes
In this episode, the founder of Obesity Canada and the Edmonton Obesity Staging System shares his personal journey from treating kidney disease in Germany to pioneering a modern, evidence-based framework for obesity care
Fortunately, testosterone replacement therapy may help reduce night sweats if low T is the underlying cause
Mood and anxiety: A smaller subset of users report mood changes or anxiety symptoms with tirzepatide